Premium
Anika Therapeutics Inc (ANIK)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | -3,77k | 54,31k | Derivative Exercise and Sale | 14,41 | 45,97k | - |
| 2026-06-03 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | 9,07k | 0,00 | Derivative Exercise and Retained Stock | - | 45,97k | 24,58% |
| 2026-05-01 | Mr. John B. HennemanLead Independent Director | 5,00k | 73,32k | Achat | 14,66 | 54,87k | 10,03% |
| 2026-04-30 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | 12,20k | 149,88k | Achat | 12,29 | 36,16k | 50,91% |
| 2026-03-15 | Mr. David ColleranInitié | -1,89k | 26,88k | Derivative Exercise and Sale | 14,20 | 67,57k | - |
| 2026-03-14 | Mr. David ColleranInitié | 13,94k | 0,00 | Derivative Exercise and Retained Stock | - | 67,57k | 26,00% |
| 2026-03-14 | Mr. David ColleranInitié | -4,17k | 59,19k | Sale to Issuer | 14,20 | 67,57k | -5,81% |
| 2026-03-14 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | -5,94k | 84,40k | Sale to Issuer | 14,20 | 23,96k | -19,87% |
| 2026-03-14 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | 12,82k | 0,00 | Derivative Exercise and Retained Stock | - | 23,96k | 115,13% |
| 2026-03-14 | Dr. Cheryl Renee BlanchardExecutive Chair | 37,55k | 0,00 | Derivative Exercise and Retained Stock | - | 270,53k | 16,12% |
| 2026-03-14 | Dr. Cheryl Renee BlanchardExecutive Chair | -14,73k | 209,14k | Sale to Issuer | 14,20 | 270,53k | -5,16% |
| 2026-03-15 | Dr. Cheryl Renee BlanchardExecutive Chair | -12,10k | 171,88k | Derivative Exercise and Sale | 14,20 | 270,53k | - |
| 2026-03-15 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | -781,00 | 11,09k | Derivative Exercise and Sale | 14,20 | 24,11k | - |
| 2026-03-14 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | 5,65k | 0,00 | Derivative Exercise and Retained Stock | - | 24,11k | 30,62% |
| 2026-03-14 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | -1,45k | 20,58k | Sale to Issuer | 14,20 | 24,11k | -5,67% |
| 2026-03-09 | Dr. Cheryl Renee BlanchardExecutive Chair | 14,13k | 0,00 | Derivative Exercise and Retained Stock | - | 223,19k | 6,76% |
| 2026-03-09 | Dr. Cheryl Renee BlanchardExecutive Chair | -5,87k | 87,83k | Derivative Exercise and Sale | 14,96 | 223,19k | - |
| 2026-03-09 | Mr. David ColleranInitié | -1,92k | 28,71k | Derivative Exercise and Sale | 14,96 | 53,10k | - |
| 2026-03-09 | Mr. David ColleranInitié | 3,55k | 0,00 | Derivative Exercise and Retained Stock | - | 53,10k | 7,16% |
| 2026-03-09 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | -639,00 | 9,56k | Derivative Exercise and Sale | 14,96 | 18,74k | - |
| 2026-03-09 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | 1,56k | 0,00 | Derivative Exercise and Retained Stock | - | 18,74k | 9,07% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
